Anti-igf antibodies

作者: Paul Adam , Eric Borges

DOI:

关键词:

摘要: Antibody molecules, in particular fully human antibodies that bind to IGF-1 and cross-react with IGF-2 such binding of the receptor is prevented receptor-mediated signaling inhibited. The do not insulin thus affect mitogenic properties are mediated by its receptors. useful for treatment hyperproliferative diseases, cancer.

参考文章(144)
Y S Lin, J L Mendoza, D Fei, N B Modi, C Nguyen, Y G Meng, E Escandon, Preclinical Pharmacokinetics, Interspecies Scaling, and Tissue Distribution of a Humanized Monoclonal Antibody against Vascular Endothelial Growth Factor Journal of Pharmacology and Experimental Therapeutics. ,vol. 288, pp. 371- 378 ,(1999)
Philip Jones, Ben Woolven, Ian Tomlinson, Greg Winter, Olga Ignatovich, Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand ,(2003)
Christilyn Graff, Kandasamy Hariharan, Scott Glaser, Ellen Garber, Stephen Demarest, Christopher L. Reyes, Anti-igf-ir antibodies and uses thereof ,(2007)
Claude Geoffrey Davis, Nobuaki Hori, Aya Jakobovits, Krisztina M. Zsebo, Production of a multimeric protein by cell fusion method ,(1997)
Rolf A. Brekken, Philip E. Thorpe, Antibody conjugate formulations for selectively inhibiting VEGF ,(2001)
G Kulik, A Klippel, M J Weber, ANTIAPOPTOTIC SIGNALLING BY THE INSULIN-LIKE GROWTH FACTOR I RECEPTOR, PHOSPHATIDYLINOSITOL 3-KINASE, AND AKT Molecular and Cellular Biology. ,vol. 17, pp. 1595- 1606 ,(1997) , 10.1128/MCB.17.3.1595
Herbert A. Runnels, Peter J. Nicastro, Karen S. Bailey, J. Alan Arbuckle, Phillip A. Morton, Antibodies to igf-i receptor for the treatment of cancers ,(2004)